Plain-English translation of NCT05147844 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new immunotherapy medication called combined with radiation therapy to treat nasopharyngeal cancer that has spread to other parts of the body. Nasopharyngeal cancer is a type of cancer that starts in the back of the nose. Currently, chemotherapy is the standard treatment for this advanced form of cancer, but many patients still don't have good long-term survival or quality of life, which is why researchers want to test whether this new treatment approach works better.
People with advanced nasopharyngeal cancer often don't survive as long or live as well as doctors hope with traditional chemotherapy alone. This trial exists to see whether the new treatment can help more patients by using their own immune system (with the immunotherapy medication) along with targeted radiation to attack the cancer more effectively.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive the new immunotherapy medication () along with radiation therapy directed at your cancer. The study involves visits to one of several participating medical centers where doctors will monitor how well the treatment works and check for any side effects. You'll have scans and blood tests at various points during the trial to see how your cancer is responding. The study is enrolling about 40 people total.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
Xinqiao Hospital of Chongqing
Collaborators
Southwest Hospital, China, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Enrollment target
~40 participants
Started
March 2022
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in July 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.